Commentary on: Improvements in Submental Contour Up to 3 Years After ATX-101: Efficacy and Safety Follow-Up of the Phase 3 REFINE Trials

Corresponding Author: Dr Sachin M. Shridharani, 880 5th Ave #1/B/C/D, New York, NY 10021, USA. E-mail: [email protected]

^*Dr Shridharani is a plastic surgeon in private practice in New York, NY, USA

^†Ms Tisch is an intern at a private practice in New York, NY, USA

Editorial Decision date: March 01, 2021; online publish-ahead-of-print April 10, 2021